Table 4.

In‐hospital and 30‐day clinical outcomes

OUTCOMES	No PAD 682 (85%)	PAD 119(15%)	Odds ratio (95% CI)	p‐value	Adjusteda odds ratio (95% CI)	p‐value
Death
In‐hospital		3 (2.5)	1.58 (0.43–5.7)	.49	1.79 (0.44–7.3)	.42
30‐days		5 (4.2)	0.86 (0.33–2.26)	.76	1.08 (0.39–3.02)	.89
NACE
In‐hospital	70 (10.3)	15 (12.6)	1.26 (0.70–2.29)	.45	1.39 (0.75–2.59)	.30
30‐days	102 (15.0)	18 (15.1)	1.01 (0.59–1.75)	.96	1.16 (0.66–2.04)	.61
CVA
In‐hospital	13 (1.9)	2 (1.7)	0.88 (0.20–3.95)	.87	1.38 (0.27–6.89)	.70
30‐days	20 (2.9)	4 (3.4)	1.15 (0.39–3.43)	.80	1.48 (0.46–4.75)	.50
AKI
In‐hospital	50 (7.3)	16 (13.5)	1.96 (1.08–3.58)	.028	1.60 (0.84–3.04)	.149
30‐days	110 (16.1)	22 (18.5)	1.18 (0.71–1.96)	.52	1.04 (0.61–1.76)	.90
VASC COMP
In‐hospital	114 (16.7)	30 (25.2)	1.68 (1.06–2.66)	.027	1.80 (1.10–2.93)	.018
30‐days	118 (17.3)	35 (29.4)	1.99 (1.28–3.10)	.002	2.15 (1.34–3.44)	.001
MAJOR VASC
In‐hospital	57 (8.4)	14 (11.8)	1.46 (0.79–2.72)	.23	1.80 (0.83–3.48)	.080
30‐days	60 (8.8)	15 (12.6)	1.50 (0.82–2.73)	.19	1.87 (0.98–3.55)	.056
MINOR VASC
In‐hospital	57 (8.4)	16 (13.5)	1.70 (0.94–3.08)	.078	1.54 (0.83–2.88)	.1.73
30‐days	60 (8.8)	20 (16.8)	2.09 (1.21–3.63)	.008	1.89 (1.06–3.37)	.030
BARC
In‐hospital	51 (7.5)	12 (10.1)	1.39 (0.72–2.69)	.33	1.48 (0.74–2.97)	.27
30‐days	63 (9.2)	13 (10.9)	1.20 (0.64–2.27)	.56	1.37 (0.70–2.64)	.36

Abbreviations: AKI, acute kidney injury; BARC, bleeding academic research consortium criteria; C‐death, cardiovascular death; CVA, cerebrovascular accident; DM, diabetes mellitus; LIFE BLEED, life threatening bleeding (VARC‐2 criteria); MAJOR VASC, major vascular complications (VARC ‐2 criteria); MI, myocardial infarction; MINOR VASC, minor vascular complications (VARC‐2 criteria); NACE, net adverse cardiovascular events; NDM, no diabetes mellitus; VASC COMP, all vascular complications (VARC‐2 criteria).

^aAdjusted for: age, sex, weight, diabetes mellitus, coronary artery disease (CAD), CKD, COPD, LVEF, Sheath size of valve system, and country.